A carregar...
Exploring brusatol as a new anti-pancreatic cancer adjuvant: biological evaluation and mechanistic studies
Pancreatic cancer is highly resistant to chemotherapeutic agents and is known to have a poor prognosis. The development of new therapeutic entities is badly needed for this deadly malignancy. In this study, we demonstrated for the first time that brusatol, a natural quassinoid isolated from a Chines...
Na minha lista:
| Publicado no: | Oncotarget |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Impact Journals LLC
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5689587/ https://ncbi.nlm.nih.gov/pubmed/29156697 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.17761 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|